PTPDC1

Across TCGA pan-cancer cohorts, PTPDC1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated PTPDC1 data layer compared with 23 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher PTPDC1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated PTPDC1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

HNSC, LUAD, and LSCC are the cancer types where PTPDC1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	III,IV	1.000	0.719	.002	32	view →
LUAD	OS	Tertile	II,III,IV	1.000	0.565	.036	4	view →
LSCC	OS	Tertile	All	0.695	0.928	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

PTPDC1–HNSC (OS)

Open the HNSC breakdown →